Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model

scientific article

Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2012.02.071
P698PubMed publication ID22406460

P50authorGary P. KobingerQ66679700
Kate E. BroderickQ87200293
Alexander BelloQ123019198
P2093author name stringNiranjan Y Sardesai
Feng Lin
Jonas Söderholm
Xuefei Shen
Derek A Gregg
P2860cites workIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageQ24531468
A history of influenzaQ28189170
A constant rate of spontaneous mutation in DNA-based microbesQ28271032
Influenza: evolving strategies in treatment and preventionQ28299371
The annual impact of seasonal influenza in the US: Measuring disease burden and costsQ29030744
Immunogenicity of novel consensus-based DNA vaccines against avian influenza.Q30359911
Influenza viruses and the evolution of avian influenza virus H5N1.Q30364962
Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaksQ30389582
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.Q30395101
Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigensQ33346277
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag proteinQ33849127
Increased DNA vaccine delivery and immunogenicity by electroporation in vivoQ33899313
Research and development of universal influenza vaccinesQ34093195
Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivoQ34265962
High-efficiency gene transfer into skeletal muscle mediated by electric pulsesQ35123357
Biochemistry of human skin--our brain on the outsideQ36347435
Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.Q37001633
Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virusQ37157152
Dendritic cells: biology of the skinQ37363179
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?Q37823343
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvementQ37836900
Electroporation delivery of DNA vaccines: prospects for successQ37870313
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporationQ38610641
Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challengeQ40092310
DNA supercoiling: Another level for regulating gene expressionQ40125224
Transformation ofEscherichia coliwith large DNA molecules by electroporationQ40394313
Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).Q40596844
Study of mechanisms of electric field-induced DNA transfection. V. Effects of DNA topology on surface binding, cell uptake, expression, and integration into host chromosomes of DNA in the mammalian cellQ41861128
Electropermeabilization of skeletal muscle enhances gene transfer in vivoQ45862087
Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA.Q45883348
A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporationQ45883425
A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.Q46593022
Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccinesQ47727853
Expression of transfected DNA depends on DNA topologyQ68727592
Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaquesQ80204825
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse musclesQ80507043
P433issue48
P407language of work or nameEnglishQ1860
P921main subjectelectroporationQ1142521
P304page(s)6946-6954
P577publication date2012-03-08
P1433published inVaccineQ7907941
P1476titleInfluenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model
P478volume30

Reverse relations

cites work (P2860)
Q33723334A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin
Q53272516A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
Q30427950Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques
Q92428731Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization
Q38791353Cytomegalovirus Vaccines: Current Status and Future Prospects.
Q38670879DNA-based influenza vaccines as immunoprophylactic agents toward universality
Q38081775Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease.
Q59349904Efforts to Improve the Seasonal Influenza Vaccine
Q37530445Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses
Q38285418Electroporation-enhanced delivery of nucleic acid vaccines
Q35680631Expression and Characterization of the RKOD DNA Polymerase in Pichia pastoris
Q34291098Fast vaccine design and development based on correlates of protection (COPs).
Q33880398Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice
Q30380290Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
Q33586294Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device
Q38647070Recent outbreaks of highly pathogenic avian influenza viruses in South Korea.
Q36069582Synthetic DNA approach to cytomegalovirus vaccine/immune therapy
Q37035833Traditional and new influenza vaccines

Search more.